Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03001843Phase 4Completed
Phase 4, open-label trial of ketamine in pain, sponsored by University of Florida. Primary endpoint: Pain Measured Based on Pain Medication Used on a Scale of 0-10 at 48 hours. Started Feb 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03001843.